Richard Weldon

Title: Richard Weldon: Innovator in Cancer Treatment

Introduction

Richard Weldon is a notable inventor based in Wädenswil, Switzerland. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic antibodies.

Latest Patents

Weldon holds a patent for "Anti-MET antibodies and methods of use thereof." This patent involves compositions, methods, and uses of antibodies that specifically bind to MET, a receptor tyrosine kinase. The invention aims to modulate the expression and activity of MET, providing potential methods for managing, treating, or preventing disorders such as cancer. The patent includes a monoclonal antibody or antigen-binding fragment that binds to the Sema/PSI domain of human MET. Additionally, it describes a method for administering a therapeutically effective amount of the antibody to subjects in need.

Career Highlights

Richard Weldon is associated with Celldex Therapeutics Limited, where he continues to advance his research in the field of oncology. His work focuses on developing innovative solutions that can significantly impact cancer treatment.

Collaborations

Weldon collaborates with esteemed colleagues such as Yan Yang and Sreekala Mandiyan, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Richard Weldon's contributions to the field of cancer treatment through his patented innovations highlight his role as a leading inventor in the biotechnology sector. His work continues to pave the way for advancements in therapeutic approaches to cancer management.